| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Physiology and Biophys [C. A., J. R. H., E. A. R., R. L. E.], Environmental Health Sciences [E. A. R.], Reproductive Biology [E. A. R., R. L. E.], Dermatology [R. L. E.], and Biochemistry [J. R. H., R. L. E.], Case Western Reserve University School of Medicine, Cleveland, Ohio 44106
In the present study, we examine the effects of all-trans-retinoic acid (RA) and interferons-
and -
(IFN-
and IFN-
) on the growth of HPV16-immortalized cell lines, ECE16-1 and CaSki. Treating proliferating ECE16-1 cells with RA causes a concentration-dependent decrease in cell number. At 1 µM RA, cell growth is suppressed by 65% and the level of mRNA encoding cytokeratin K5, a biochemical marker of retinoid action, is also suppressed. In contrast, the level of transcript encoding the HPV16 oncogenes, E6 and E7, is reduced by only 5 to 10%. IFN-
at 1000 IU/ml or IFN-
at 200 IU/ml suppresses growth by 70%. This growth suppression by IFN-
is correlated with a >90% reduction in E6/E7 mRNA levels. Additional growth suppression is observed upon simultaneous treatment with retinoid and interferon. Optimal suppression is observed in the presence of 200 IU/ml IFN-
and 1 µM RA. The rank order of effectiveness is IFN-
/RA > IFN-
/RA = IFN-
> RA > IFN-
. In contrast to the suppression of ECE16-1 cell growth, RA causes a concentration-dependent increase in CaSki cell number (5060%) which is optimal at 1 µM RA. Cytokeratin K5 mRNA levels are markedly suppressed, and E6/E7 mRNA levels increased by 5% under these conditions. IFN-
at 1000 IU/ml or IFN-
at 200 IU/ml decreases CaSki cell growth by 20 and 45%, respectively, and 200 IU/ml of IFN-
reduce E6/E7 expression to undetectable levels. Addition of RA (1 µM) partially counters the IFN-dependent suppression of growth and E6/E7 mRNA levels. Our results suggest that retinoid-dependent changes in human papillomavirus-immortalized cervical cell proliferation are not always correlated with changes in E6/E7 transcript levels.
1 This work was supported by a grant from the American Institute for Cancer Research (R. L. E.) and utilized the facilities of the Skin Diseases Research Center of Northeast Ohio (NIH, AR39750). J. R. H. was supported by the Metabolism Training Program (NIH, DK07319).
2 To whom requests for reprints should be addressed, at Department of Physiology and Biophysics, Room E532, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4970.
Received 7/ 2/93. Accepted 2/15/94.
This article has been cited by other articles:
![]() |
J. A. Johnson and J. D. Gangemi Alpha Interferon Augments Cidofovir's Antiviral and Antiproliferative Activities Antimicrob. Agents Chemother., June 1, 2003; 47(6): 2022 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Sah, R. L. Eckert, R. A. S. Chandraratna, and E. A. Rorke Retinoids Suppress Epidermal Growth Factor-associated Cell Proliferation by Inhibiting Epidermal Growth Factor Receptor-dependent ERK1/2 Activation J. Biol. Chem., March 15, 2002; 277(12): 9728 - 9735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Einstein, Y. Cruz, M. K. El-Awady, N. C. Popescu, J. A. DiPaolo, M. van Ranst, A. S. Kadish, S. Romney, C. D. Runowicz, and R. D. Burk Utilization of the Human Genome Sequence Localizes Human Papillomavirus Type 16 DNA Integrated into the TNFAIP2 Gene in a Fatal Cervical Cancer from a 39-Year-Old Woman Clin. Cancer Res., February 1, 2002; 8(2): 549 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Kim, L. Blatt, and M. W. Taylor The effects of interferon on the expression of human papillomavirus oncogenes J. Gen. Virol., March 1, 2000; 81(3): 695 - 700. [Abstract] [Full Text] |
||||
![]() |
S. M. Thacher, S. Nagpal, E. S. Klein, T. Arefieg, G. Krasinski, D. DiSepio, C. Agarwal, A. Johnson, R. L. Eckert, and R. A. S. Chandraratna Cell Type and Gene-specific Activity of the Retinoid Inverse Agonist AGN 193109: Divergent Effects from Agonist at Retinoic Acid Receptor {{gamma}} in Human Keratinocytes Cell Growth Differ., April 1, 1999; 10(4): 255 - 262. [Abstract] [Full Text] |
||||
![]() |
C. Agarwal, A. Lambert, R. A.S. Chandraratna, E. A. Rorke, and R. L. Eckert Vitamin D Regulates Human Ectocervical Epithelial Cell Proliferation and Insulin-Like Growth Factor-Binding Protein-3 Level Biol Reprod, March 1, 1999; 60(3): 567 - 572. [Abstract] [Full Text] |
||||
![]() |
C. Agarwal, R. A. S. Chandraratna, A. T. Johnson, E. A. Rorke, and R. L. Eckert AGN193109 Is a Highly Effective Antagonist of Retinoid Action in Human Ectocervical Epithelial Cells J. Biol. Chem., May 24, 1996; 271(21): 12209 - 12212. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |